Development of new corona vaccine Nation's 9 researches have helped the country by over 7 billion yen May 22 15:17
In order to promote the development of a new coronavirus vaccine, the government has decided to subsidize more than 7 billion yen for nine domestic studies. One of these is expected to start clinical trials in July, so there are expectations for early development.
Regarding the development of a new coronavirus vaccine, the Ministry of Health, Labor and Welfare has set a supplementary budget of 10 billion yen for this fiscal year to support basic research and part of clinical trials.
Regarding the research to be supported, “Japan Medical Research and Development Organization” = AMED made an open call for participants, and adopted a total of 9 cases, including 4 company-led cases and 5 university-led cases.
Company-led companies such as pharmaceutical companies are 124 million yen for "ID Pharma" in Chiyoda-ku, Tokyo, 1,309 million yen for "Shionogi Pharmaceutical" in Osaka City, and 1,061 million yen for "KM Biologics" in Kumamoto City. Yen, 2 billion yen for "Angesu" in Ibaraki City, Osaka.
In the initiative of universities, it will be 258 million yen for Keio University, 200 million yen for the University of Tokyo, 50 million yen for Nagasaki University, 38 million yen for Niigata University, and 500 million yen for the Tokyo Metropolitan Institute of Medical Research. I am.
According to the Japan Medical Research and Development Organization, the total of 7.2 billion yen will be subsidized for the 9 studies including other expenses.
The usage of the remaining 2.8 billion yen out of the 10 billion yen included in the supplementary budget is undecided.
According to the Ministry of Health, Labor and Welfare, of the nine studies, the one that "Angesu" is promoting in collaboration with Osaka University is expected to begin clinical trials in July, so there are expectations for early development.